16 articles tagged with "health"
The director of the WHO's Eastern Mediterranean region is contemplating a bid for the director-general position as tensions rise over the situation in Iran and surrounding areas.
As Dana-Farber Cancer Institute charts its course away from Mass General Brigham, CEO Benjamin Ebert shares his vision for a new hospital and the future of cancer care.
The recent approval of a breakthrough drug for a rare disease highlights ongoing issues in access, particularly for adult patients.
Revolution Medicines announced that its pancreatic cancer drug has shown success in a crucial Phase 3 trial, raising hopes for patients and the medical community.
In a significant move, Maryland's State Affordability Board has initiated a process to establish a price cap for Jardiance, a medication for type 2 diabetes, with a target date set for January 2027.
An FDA analysis reveals that almost 30% of clinical trials, likely subject to mandatory reporting, have not submitted their results, prompting calls for accountability from drug manufacturers.
A federal judge has dismissed a lawsuit related to the California No Surprises Act against HaloMD, a key player in out-of-network billing disputes for medical providers.
A remote patient monitoring company is adapting its technology to participate in Medicare's ACCESS experiment, which aims to improve health care outcomes through aligned payments.
Despite President Trump's promises to challenge health insurers, his policies appear to contradict those commitments, suggesting a softer stance.
In a recent trial, patients with metastatic pancreatic cancer who received a new medication from Revolution Medicines reportedly lived twice as long as those treated with chemotherapy.
As the healthcare landscape evolves, the transition of nurses into expert roles presents both opportunities and challenges, with implications for future healthcare delivery.
Recent findings indicate that Allogene Therapeutics’ CAR-T therapy effectively targets residual cancer cells in B-cell lymphoma patients, potentially delaying recurrence.
Spyre Therapeutics has reported positive results from its first major trial of a drug aimed at treating inflammatory bowel disease, positioning itself against larger pharmaceutical companies.
Several hospitals are beginning to implement chatbots, a bold move intended to enhance communication with existing patients while attracting new ones.
Erectile dysfunction extends beyond mere sexual concerns, impacting various aspects of life and well-being.
The position of head of the FDA's Center for Biologics Evaluation and Research presents significant challenges for any successor.